Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Non-GAAP effective tax rate by Year
Non-GAAP effective tax rate (%) (%)
Vertex Pharmaceuticals Non-GAAP effective tax rate: 17.3% in FY2025, down 73.7 pts from a year earlier.
Where the FY2025 figure comes from
“|| Non-GAAP effective tax rate | 13.5 | % | 21.3 | % | 17.3 | % | 91.0 | % 12Vertex Pharmaceuticals Incorporated”
Source: Form 8-K (ex-991_q42025.htm, filed 2026-02-12) ↗
Reported in Form 8-K EX-99.1 Earnings Releases (GAAP to Non-GAAP Reconciliations).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Non-GAAP effective tax rate (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 17.3% | -73.7 pts | Form 8-K (ex-991_q42025.htm, filed 2026-02-12) ↗ |
| FY2024 | Dec 31, 2024 | 91.0% | +71.6 pts | Form 8-K (ex-991_q42025.htm, filed 2026-02-12) ↗ |
| FY2023 | Dec 31, 2023 | 19.4% | -1.4 pts | Form 8-K (ex-991_q42024.htm, filed 2025-02-10) ↗ |
| FY2022 | Dec 31, 2022 | 20.8% | +0.2 pts | Form 8-K (ex-991_q42023.htm, filed 2024-02-05) ↗ |
| FY2021 | Dec 31, 2021 | 20.6% | -0.4 pts | Form 8-K (ex-991_q42022.htm, filed 2023-02-07) ↗ |
| FY2020 | Dec 31, 2020 | 21.0% | – | Form 8-K (ex-991_q42021.htm, filed 2022-01-26) ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals Non-GAAP effective tax rate (%), annual FY2020–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/nongaap-etr
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.